Browsing byAuthorYoung, PM

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 51  next >
Issue DateTitleAuthor(s)
2018-01-01Aerosol particle transport and deposition in a CT-based lung airway for helium-oxygen mixtureIslam, MS; Saha, SC; Young, PM
2018-01-01Aerosol particle transport and deposition in a CT-based lung airway for helium-oxygen mixtureIslam, MS; Saha, SC; Young, PM
2018-01-01Aerosol particle transport and deposition in a CT-based lung airway for helium-oxygen mixtureIslam, MS; Saha, SC; Young, PM
2020-11An in vitro model for assessing drug transport in cystic fibrosis treatment: Characterisation of the CuFi-1 cell line.Sheikh, Z; Bradbury, P; Pozzoli, M; Young, PM; Ong, HX; Traini, D
2016-02-15Antibiotic transport across bronchial epithelial cells: Effects of molecular weight, LogP and apparent permeabilityStigliani, M; Haghi, M; Russo, P; Young, PM; Traini, D
2016-10-01Application of RPMI 2650 nasal cell model to a 3D printed apparatus for the testing of drug deposition and permeation of nasal productsPozzoli, M; Ong, HX; Morgan, L; Sukkar, M; Traini, D; Young, PM; Sonvico, F
2010-08-01Artesunate-clindamycin multi-kinetics and site-specific oral delivery system for antimalaric combination productsStrusi, OL; Barata, P; Traini, D; Young, PM; Mercuri, S; Colombo, G; Sonvico, F; Bettini, R; Colombo, P
2011-01Cellular release profiling of controlled release dry powder pulmonary formulationOng, HX; Traini, D; Bebawy, M; Young, P; Dalby, RN; Byron, PR; Peart, J; Suman, JD; Young, PM
2010-01Characterization of P-gp Expression and Function vs. Time and Passage in the Calu-3 Air-Interface Model for Drug Delivery to the LungHaghi, M; Young, P; Traini, D; Bebawy, M; Dalby, RN; Byron, PR; Peart, J; Suman, JD; Farr, SJ; Young, PM
2011-09-01Chronic obstructive pulmonary disease: Patho-physiology, current methods of treatment and the potential for simvastatin in disease managementMarin, L; Colombo, P; Bebawy, M; Young, PM; Traini, D
2013-06-01Ciprofloxacin is actively transported across bronchial lung epithelial cells using a calu-3 air interface cell modelOng, HX; Traini, D; Bebawy, M; Young, PM
2016-03-30Combination of Silver Nanoparticles and Curcumin Nanoparticles for Enhanced Anti-biofilm ActivitiesLoo, CY; Rohanizadeh, R; Young, PM; Traini, D; Cavaliere, R; Whitchurch, CB; Lee, WH
2014-08COMBINATION THERAPY OF CURCUMIN AND SILVER NANOPARTICLES WITH ENHANCED ANTI-BIOFILM ACTIVITY FOR TREATMENT OF ENDOTRACHEAL TUBE-ASSOCIATED INFECTIONSLoo, C-Y; Young, PM; Lee, W-H; Traini, D; Cavaliere, R; Whitchurch, CB; Rohanizadeh, R
2011-01Comparison of albuterol sulphate and base dry powder particulate deposition using the Calu-3 lung epithelial modelHaghi, M; Traini, D; Bebawy, M; Young, P; Dalby, RN; Byron, PR; Peart, J; Suman, JD; Young, PM
2015-06-01CURCUMIN AND SILVER NANOPARTICLE HYDROGELS FOR ENDOTRACHEAL TUBE-ASSOCIATED INFECTIONS: CHARACTERIZATION AND ANTI-BIOFILM ACTIVITIESLoo, J; Lee, W-H; Young, PM; Traini, D; Cavaliere, R; Whitchurch, CB; Rohanizadeh, R
2012-06-04Deposition, diffusion and transport mechanism of dry powder microparticulate salbutamol, at the respiratory epitheliaHaghi, M; Traini, D; Bebawy, M; Young, PM
2017-09-02Development of a Soluplus budesonide freeze-dried powder for nasal drug deliveryPozzoli, M; Traini, D; Young, PM; Sukkar, MB; Sonvico, F
2015-06-01Development of an inhaled controlled release voriconazole dry powder formulation for the treatment of respiratory fungal infectionArora, S; Haghi, M; Loo, CY; Traini, D; Young, PM; Jain, S
2016-10-02Dry powder nasal drug delivery: challenges, opportunities and a study of the commercial Teijin Puvlizer Rhinocort device and formulationPozzoli, M; Rogueda, P; Zhu, B; Smith, T; Young, PM; Traini, D; Sonvico, F
2020-04Effect of continuous positive airway pressure treatment on permeability, inflammation and mucus production of human epithelial cells.Grau-Bartual, S; Al-Jumaily, AM; Young, PM; Traini, D; Ghadiri, M